Koligo Therapeutics (ASX:KOL) Other Current Liabilities: A$0.00 Mil (As of . 20)


What is Koligo Therapeutics Other Current Liabilities?

Koligo Therapeutics ASX:KOL Other Current Liabilities is A$0.00 Mil as of . 20.

Koligo Therapeutics's other current liabilities for the quarter that ended in . 20 was A$0.00 Mil.

Koligo Therapeutics Other Current Liabilities Related Terms

Koligo Therapeutics Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Koligo Therapeutics's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Koligo Therapeutics Other Current Liabilities Chart

Koligo Therapeutics Annual Data
Trend
Other Current Liabilities

Koligo Therapeutics Semi-Annual Data
Other Current Liabilities

Koligo Therapeutics Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of A$0.00 Mil mean?
Koligo Therapeutics (ASX:KOL) has a Other Current Liabilities of A$0.00 Mil as of . 20. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Koligo Therapeutics.
Is Koligo Therapeutics' Other Current Liabilities too high?
Koligo Therapeutics' current Other Current Liabilities is A$0.00 Mil.
How does Koligo Therapeutics' Other Current Liabilities compare to ?
Koligo Therapeutics' Other Current Liabilities of A$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Koligo Therapeutics. Koligo Therapeutics's current Other Current Liabilities is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Koligo Therapeutics stock overvalued right now?
Koligo Therapeutics (ASX:KOL) has a current Other Current Liabilities of A$0.00 Mil. The current Other Current Liabilities is A$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Koligo Therapeutics (ASX:KOL), the current Other Current Liabilities is A$0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Koligo Therapeutics Business Description

Comparable Companies